GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,331,000 | -84.2% | 181,226 | -90.3% | 0.00% | -100.0% |
| Q4 2020 | $27,332,000 | +0.6% | 1,872,073 | -2.1% | 0.00% | 0.0% |
| Q3 2020 | $27,156,000 | -5.1% | 1,912,424 | -1.7% | 0.00% | -25.0% |
| Q2 2020 | $28,625,000 | +227.7% | 1,945,978 | -8.2% | 0.00% | +300.0% |
| Q1 2020 | $8,735,000 | -14.1% | 2,120,047 | +0.3% | 0.00% | 0.0% |
| Q4 2019 | $10,166,000 | -44.1% | 2,113,579 | -29.6% | 0.00% | -66.7% |
| Q3 2019 | $18,181,000 | -57.5% | 3,000,151 | -54.5% | 0.00% | -50.0% |
| Q2 2019 | $42,766,000 | -21.6% | 6,589,491 | -14.3% | 0.01% | -25.0% |
| Q1 2019 | $54,530,000 | +37.8% | 7,691,133 | -5.6% | 0.01% | +14.3% |
| Q4 2018 | $39,582,000 | -37.8% | 8,144,394 | -5.9% | 0.01% | -22.2% |
| Q3 2018 | $63,631,000 | +12.6% | 8,657,319 | -2.3% | 0.01% | 0.0% |
| Q2 2018 | $56,513,000 | +16.9% | 8,857,766 | -0.3% | 0.01% | +12.5% |
| Q1 2018 | $48,351,000 | +31.3% | 8,888,010 | +0.6% | 0.01% | +33.3% |
| Q4 2017 | $36,828,000 | -42.0% | 8,831,638 | +33.8% | 0.01% | -45.5% |
| Q3 2017 | $63,545,000 | +8.3% | 6,598,608 | +33.0% | 0.01% | 0.0% |
| Q2 2017 | $58,680,000 | +14.3% | 4,960,231 | +23.8% | 0.01% | +10.0% |
| Q1 2017 | $51,361,000 | +8.2% | 4,006,320 | +3.3% | 0.01% | +11.1% |
| Q4 2016 | $47,489,000 | +6.7% | 3,879,814 | +2.9% | 0.01% | 0.0% |
| Q3 2016 | $44,502,000 | +91.7% | 3,771,354 | +41.3% | 0.01% | +80.0% |
| Q2 2016 | $23,218,000 | +65.0% | 2,668,754 | -0.1% | 0.01% | +66.7% |
| Q1 2016 | $14,072,000 | -29.8% | 2,670,154 | +3.4% | 0.00% | -25.0% |
| Q4 2015 | $20,043,000 | +0.5% | 2,582,854 | +1.9% | 0.00% | 0.0% |
| Q3 2015 | $19,945,000 | -14.2% | 2,534,354 | -1.2% | 0.00% | -20.0% |
| Q2 2015 | $23,235,000 | -30.2% | 2,564,554 | +0.1% | 0.01% | -28.6% |
| Q1 2015 | $33,268,000 | -4.8% | 2,563,054 | -0.2% | 0.01% | 0.0% |
| Q4 2014 | $34,961,000 | +50.7% | 2,568,754 | -0.7% | 0.01% | +40.0% |
| Q3 2014 | $23,203,000 | -33.6% | 2,586,754 | +0.2% | 0.01% | -37.5% |
| Q2 2014 | $34,939,000 | +32.1% | 2,582,354 | -2.9% | 0.01% | +33.3% |
| Q1 2014 | $26,439,000 | -62.6% | 2,659,900 | -49.9% | 0.01% | -25.0% |
| Q4 2013 | $70,678,000 | +38.1% | 5,310,200 | +26.0% | 0.01% | -38.5% |
| Q3 2013 | $51,195,000 | -36.4% | 4,213,600 | -45.9% | 0.01% | +18.2% |
| Q2 2013 | $80,522,000 | – | 7,787,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 500,000 | $6,765,000 | 5.83% |
| Gruss & Co., LLC | 200,000 | $2,706,000 | 3.07% |
| First Light Asset Management, LLC | 150,076 | $2,031,000 | 1.37% |
| Curi RMB Capital, LLC | 1,032,369 | $13,968,000 | 0.88% |
| Camber Capital Management LP | 908,100 | $12,287,000 | 0.80% |
| CADIAN CAPITAL MANAGEMENT, LP | 887,500 | $12,008,000 | 0.36% |
| PARNASSUS INVESTMENTS, LLC | 2,118,127 | $28,658,000 | 0.25% |
| Visium Asset Management, LP | 786,468 | $10,641,000 | 0.16% |
| PUTNAM INVESTMENTS LLC | 5,198,367 | $70,333,000 | 0.15% |
| Capital Impact Advisors, LLC | 13,933 | $189,000 | 0.14% |